(Q73025091)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11013202%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

title

Dexamethasone concentration in the subretinal fluid after a subconjunctival injection, a peribulbar injection, or an oral dose (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11013202%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11013202%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Fred Romijn

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11013202%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

author name string

O Weijtens

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11013202%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

E G Lentjes

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11013202%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

A F Cohen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11013202%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

J C van Meurs

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11013202%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

publication date

1 October 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11013202%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11013202%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

107

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11013202%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11013202%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

1932-1938

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11013202%20AND%20SRC:MED&resulttype=core&format=json

Changing Concepts of Failures After Retinal Detachment Surgery

31 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900344-4

7 January 2021

Clinical factors predisposing to massive proliferative vitreoretinopathy in rhegmatogenous retinal detachment

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900344-4

7 January 2021

Post-operative outcome in rhegmatogenous retinal detachment

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900344-4

7 January 2021

Clinical risk factors for proliferative vitreoretinopathy after retinal detachment surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900344-4

7 January 2021

[Vitrectomy in proliferative vitreoretinopathy. Anatomical and functional results in 501 patients]

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900344-4

7 January 2021

Therapeutic effect of periocular corticosteroids in experimental proliferative vitreoretinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900344-4

7 January 2021

Improvement in efficacy of corticosteroid therapy in an animal model of proliferative vitreoretinopathy by pretreatment

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900344-4

7 January 2021

Corticosteroids and daunomycin in the prevention of experimental proliferative vitreoretinopathy induced by macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900344-4

7 January 2021

Quantification of Cellular Proliferation in Experimental Proliferative Vitreoretinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900344-4

7 January 2021

Postoperative retinal fibrosis--a controlled clinical study of systemic steroid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900344-4

7 January 2021

Peribulbar corticosteroid injection: vitreal and serum concentrations after dexamethasone disodium phosphate injection

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900344-4

7 January 2021

Dexamethasone concentration in vitreous and serum after oral administration

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900344-4

7 January 2021

High concentration of dexamethasone in aqueous and vitreous after subconjunctival injection.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900344-4

7 January 2021

Ciprofloxacin and dexamethasone inhibit the proliferation of human retinal pigment epithelial cells in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900344-4

7 January 2021

Selection of therapeutic agents for intraocular proliferative disease. Cell culture evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900344-4

7 January 2021

Controlled drainage of subretinal and choroidal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900344-4

7 January 2021

Retinal folds through the macula

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900344-4

7 January 2021

Effect of derivatization of the bioavailability of ophthalmic steroids. Development of an in vitro method of evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900344-4

7 January 2021

Human massive periretinal proliferation. In vitro characteristics of cellular components

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900344-4

7 January 2021

Pigment Epithelial Proliferation in Human Retinal Detachment with Massive Periretinal Proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900344-4

7 January 2021

Pathogenic mechanisms in proliferative vitreoretinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900344-4

7 January 2021

Localization and quantitation of blood-retinal barrier breakdown in experimental proliferative vitreoretinopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900344-4

7 January 2021

The Role of Breakdown of the Blood-Retinal Barrier in Cell-Injection Models of Proliferative Vitreoretinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900344-4

7 January 2021

Intravitreal chemotactic and mitogenic activity. Implication of blood-retinal barrier breakdown

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900344-4

7 January 2021

Intravitreous fibronectin and platelet-derived growth factor. New model for traction retinal detachment

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900344-4

7 January 2021

Serum contains chemoattractants for human retinal pigment epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900344-4

7 January 2021

Treatment with intravitreal steroid reduces blood-retinal barrier breakdown due to retinal photocoagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900344-4

7 January 2021

Dexamethasone and indomethacin attenuate cryopexy. Induced breakdown of the blood-retinal barrier

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900344-4

7 January 2021

Cryotherapy causes extensive breakdown of the blood-retinal barrier. A comparison with argon laser photocoagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900344-4

7 January 2021

Effect of argon laser photocoagulation on the permeability of the blood-retinal barrier

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900344-4

7 January 2021

Dexamethasone induced proliferation of cultured retinal pigment epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900344-4

7 January 2021

Anti-inflammatory mechanisms of glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900344-4

7 January 2021

Ocular complications associated with retrobulbar injections

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900344-4

7 January 2021

Needle penetration of the globe during retrobulbar and peribulbar injections

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900344-4

7 January 2021

10.1016/S0161-6420(00)00344-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11013202%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference